Goldman Sachs expects Nvidia ’beat and raise,’ lifts price target to $240
Director Imran Mir A of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) purchased 2,083,334 shares of Class A Common Stock at $0.605 per share, for a total transaction value of $1,260,417. The purchase price represents a significant discount to the current trading price of $1.78, with the stock showing strong momentum, up 46% over the past six months. According to InvestingPro data, analysts have set price targets between $8 and $10, suggesting potential upside.
The transaction, which occurred on October 23, 2025, was reported in a Form 4 filing with the Securities and Exchange Commission on October 27, 2025.
In addition to the purchase of Class A Common Stock, Imran Mir A also acquired 2,083,334 warrants to purchase Class A Common Stock.
In other recent news, Rani Therapeutics Holdings, Inc. has made significant developments that could impact its future operations. The company announced the closing of a $60.3 million private placement, led by Samsara BioCapital, with participation from RA Capital Management and other investors. This financial move coincides with a collaboration and license agreement with Chugai Pharmaceutical Co., Ltd., which includes a $10 million upfront payment to Rani and potential earnings of up to $75 million in technology transfer and development milestones. Additionally, Rani could earn up to $100 million in sales milestones and single-digit royalties on product sales as part of this deal.
In board-related news, Rani Therapeutics appointed Abraham Bassan and Vasudev Bailey, Ph.D., to its Board of Directors, following the resignation of Andrew Farquharson and Maulik Nanavaty. The company clarified that these resignations were not due to any disagreements regarding company operations or policies. These developments indicate a strategic shift as Rani advances its oral biologics delivery platform. The recent appointments and financial influx suggest a focused effort on expanding its capabilities and partnerships.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.